繁體中文 简体中文 English 日本語
Back to Top
AI Assistant
Prescriptions
Feminine Care

KANFU CREAM

Indications
Eczema (atopic, contact, seborrheic, folliculitis, curvilinear, post-traumatic infection, nummular, stagnant, and infantile eczema), vulvar pruritus, neurodermatitis, otitis externa, anal pruritus, and psoriasis.
View License
View Package Insert
Back to Product List
Home
Products
Prescriptions
Feminine Care
KANFU CREAM
Dosage and Administration
Ingredients

Apply an appropriate amount to the affected area 2 ~ 3 times daily.

Each gm includes:

  • Nystatin 100000 IU
  • Neomycin (as sulfate) 2.5 mg
  • Gramicidin 0.25 mg (potency)
  • Triamcinolone Acetonide 1 mg
Dosage and Administration

Apply an appropriate amount to the affected area 2 ~ 3 times daily.

Ingredients

Each gm includes:

  • Nystatin 100000 IU
  • Neomycin (as sulfate) 2.5 mg
  • Gramicidin 0.25 mg (potency)
  • Triamcinolone Acetonide 1 mg

Precautions

I. Warnings and Precautions

  1. If the treated area expands, avoid increased systemic absorption of adrenal cortex hormones.
  2. If skin irritation occurs, discontinue application immediately and seek medical attention if necessary.
  3. This medicine is for external use only. Do not apply to the eyes or oral mucosa.
  4. To prevent recurrence, continue use for a period of time after symptoms disappear until the infection is completely resolved.
  5. Unless directed by a physician, avoid bandaging the affected area while using this product.
  6. Pregnant women, breastfeeding women, and children should use this product with caution after assessing the benefits and risks.
  7. Use with caution in patients with a history of allergy to the following medications: Amikacin, Gentamycin, Kanamycin, Neomycin, Streptomycin, Tobramycin.

    8. If symptoms do not significantly improve after 1 ~ 2 weeks of use, alternative medications should be considered. Keep out of reach of children. Store in a cool place, away from direct sunlight. When using this medication for vaginal infections, both partners should be treated simultaneously to prevent recurrence due to cross-infection. This medication is contraindicated in tuberculous lesions or viral skin conditions such as smallpox, herpes simplex, and chickenpox. Prolonged or inappropriate use of topical corticosteroids can lead to rebound reactions (topical steroid withdrawal) after treatment cessation. Severe rebound reactions may extend beyond the initial treatment site, and symptoms may include dermatitis with intense redness, stinging, and burning sensations, especially when used on delicate skin areas such as the face and curved areas. If these symptoms reappear within days to weeks after successful treatment, a rebound reaction should be suspected. If you need to re-use topical corticosteroids, please carefully assess their clinical benefits and risks, or consider alternative treatment options.

     

    II. Important Clinical Side Effects / Adverse Reactions

  8. Occasionally, discomfort such as rash, peeling, itching, and burning may occur.
  9. Skin and subcutaneous tissue diseases – withdrawal reactions (frequency unknown): Redness of the skin, which may spread beyond the initial treatment area, burning or stinging sensation, itching, skin peeling, and oozing.

More Products

/
Where to Buy